Supplement Industry Warnings Near 2016 Total Midway Through 2017

FDA warning letters to herbal supplement firms in Alabama and New York add to the agency's list of supplement marketers making drug claims for their products, including statements suggesting products could address cancer, sexual health and heart and prostate issues.